1. Home
  2. ZLAB vs PFS Comparison

ZLAB vs PFS Comparison

Compare ZLAB & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.19

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Provident Financial Services Inc

PFS

Provident Financial Services Inc

HOLD

Current Price

$23.51

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
PFS
Founded
2013
1839
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.7B
IPO Year
2017
2002

Fundamental Metrics

Financial Performance
Metric
ZLAB
PFS
Price
$17.19
$23.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$49.60
$23.75
AVG Volume (30 Days)
897.9K
755.4K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
4.28%
EPS Growth
38.46
112.38
EPS
N/A
0.61
Revenue
$460,156,000.00
$73,109,000.00
Revenue This Year
$9.75
$0.68
Revenue Next Year
$26.03
$5.97
P/E Ratio
N/A
$38.11
Revenue Growth
15.33
7.06
52 Week Low
$15.96
$15.92
52 Week High
$41.20
$23.98

Technical Indicators

Market Signals
Indicator
ZLAB
PFS
Relative Strength Index (RSI) 39.76 65.09
Support Level $17.11 $21.52
Resistance Level $19.49 $23.98
Average True Range (ATR) 0.61 0.44
MACD 0.04 0.15
Stochastic Oscillator 33.73 95.70

Price Performance

Historical Comparison
ZLAB
PFS

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: